Human skeletal muscle xenograft as a new preclinical model for muscle disorders - Wikidata - wikimedia - TriplyDB

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

http://www.wikidata.org/entity/Q33649287

about

Facioscapulohumeral dystrophy: the path to consensus on pathophysiology Therapies for sarcopenia and regeneration of old skeletal muscles: more a case of old tissue architecture than old stem cells Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution Emerging preclinical animal models for FSHD.Lmo7 is dispensable for skeletal muscle and cardiac function.Human Satellite Cell Transplantation and Regeneration from Diverse Skeletal Muscles.Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts.Striated muscle function, regeneration, and repair Minimally Invasive Muscle Embedding (MIME) - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis.Facioscapulohumeral Muscular Dystrophy.Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy.

P2860

Q21195884-79A5CAC1-7D96-428F-A544-A7571CB313D2 Q26852708-0B6614D3-C1B7-4AF7-A1C6-7C88DD86E57F Q27321253-A046FCDC-B84D-4DE2-95D8-BEFDE6DED326 Q28083324-1FCF234C-BCDB-4E71-AD0A-74EB8C35ABE7 Q35582587-08630DFE-E74B-4BFF-8C20-C8A5B5B525F4 Q36122610-51C74406-39CA-46F9-8BC6-CB9E8C6F360D Q36201566-FC30CEC1-114A-469B-95D6-3298ED2092CF Q36406869-9CDA6941-0401-4BFE-A2A5-4FBD2CF917F6 Q37021623-BF2B2D7D-1890-4319-926A-ABF30E29A14D Q37256163-18D003B4-97D4-4FEC-8078-C4AA265708F6 Q38269131-FBBAEA39-A62F-4CE2-A889-51266D593B33 Q38658555-8344C3C3-4B2E-4ADE-A6DC-D3B45963E108 Q38857890-2505378D-0C51-42E0-957A-FA43CCF08EE9 Q42364257-8E640D8E-70F4-42C6-8BF1-4522621EDDDD Q52506936-8C470AA4-681F-4A7F-A5B6-7BB888CBC861 Q55092205-70E4F29C-E340-4FA7-A22C-88142DB9E916

P2860

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

http://www.wikidata.org/entity/Q33649287

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@ast

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@en

type

label

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@ast

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@en

prefLabel

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@ast

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@en

P1433

Q33649287-AF100F8B-259F-4E7E-9BE7-1924E9166622

P1476

Q33649287-25DFD351-6B02-41A6-B03A-D207CD188CF5

P2093

Q33649287-45198538-09D7-4812-B36F-5261DFFA3DCF

Q33649287-5CFDB908-4FBF-4C4C-9118-5CC1F019895A

Q33649287-8AFFBF53-CFA5-47F0-9CF6-F111C85B8236

Q33649287-91E63B20-9982-4F0E-AE3C-B15158D57B35

Q33649287-A68FF147-A169-48AD-A828-CE401BFA611D

Q33649287-AA103B22-A9D7-4304-AB7C-711D7796B33E

Q33649287-B54B3303-974B-47D0-9364-177C0BBA143A

Q33649287-BED611E2-5764-4091-A69D-B3D87D5BA0E6

Q33649287-BF0A5C43-EC0A-4635-AC7C-DC130FEF7E7E

Q33649287-E631A262-A520-4931-B27C-18EED1941B8E

P2860

Q33649287-062A9364-63BD-403B-9E74-01B1CFA4F07A

Q33649287-0BB285DF-C7CB-4BB4-8F91-201A2B65FE12

Q33649287-1FE2F6F9-4DEB-4629-A292-4341E5CAA2DA

Q33649287-204BE124-B616-476C-95EE-CF8C4F1E0BEB

Q33649287-2A8D9260-1DEB-4CBA-9409-E7A9593A8B49

Q33649287-2D23A6DE-3007-4741-8257-512C41BE6D5D

Q33649287-3AD6776C-A7AB-4546-9A42-410F72743735

Q33649287-3E6FC702-2CA3-4895-916D-7CB8D5A57D87

Q33649287-46D766B4-5D89-46F9-A702-76EEC0939E5E

Q33649287-55063E6C-BDDA-457D-8C64-610526450934

P304

Q33649287-EB3EC6F8-AAD1-4DAC-B9A1-7ECBAD4D2E9C

P31

Q33649287-E3D575DA-88C3-45E5-8EE3-8AE01167D2EC

P356

Q33649287-CB9BEACE-F351-4D54-B803-41ED72BB3E36

P433

Q33649287-F4AC25DA-F101-4C8A-89A2-153A6D22590A

P478

Q33649287-F403FF8D-8880-4D2A-A45F-3A957C50BA8E

P50

Q33649287-F8DF8A0A-1AAA-4BA0-BB3B-AF22BBDD11C7

P577

Q33649287-EA72F1A3-BF69-48C1-AAAD-5DB94A9A220B

P5875

Q33649287-3606C77C-632E-4998-BB93-8445D0BFC75F

P698

Q33649287-0DC0C8D1-30A1-4AFF-A8A7-1BC8A7329AA2

P921

Q33649287-8C2568F9-A192-488A-B491-CC3DD3D72443

P932

Q33649287-8C87888D-5F99-4B69-9A7F-34B4B3A09B3D

P356

P1433

Human Molecular Genetics

P1476

Human skeletal muscle xenograft as a new preclinical model for muscle disorders

@en

P2093

Charles P Emerson

http://www.w3.org/2001/XMLSchema#string

Christopher W Ward

http://www.w3.org/2001/XMLSchema#string

Fedik Rahimov

http://www.w3.org/2001/XMLSchema#string

Kathryn R Wagner

http://www.w3.org/2001/XMLSchema#string

Louis M Kunkel

http://www.w3.org/2001/XMLSchema#string

Naili Liu

http://www.w3.org/2001/XMLSchema#string

Oliver D King

http://www.w3.org/2001/XMLSchema#string

Takako I Jones

http://www.w3.org/2001/XMLSchema#string

Terence A Partridge

http://www.w3.org/2001/XMLSchema#string

Yuanfan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD

Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene

Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy

Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis

Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1

A unifying genetic model for facioscapulohumeral muscular dystrophy

Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse

The mdx mouse model as a surrogate for Duchenne muscular dystrophy

FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit

Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy

P304

3180-3188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU028

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259877339

http://www.w3.org/2001/XMLSchema#string

P698

24452336

http://www.w3.org/2001/XMLSchema#string

P921

P932

4030773

http://www.w3.org/2001/XMLSchema#string